Agenus Inc Sample Contracts

SECURITIES PURCHASE AGREEMENT (as amended to date)
Securities Purchase Agreement • September 19th, 2013 • Agenus Inc • Biological products, (no disgnostic substances) • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of September 18, 2013, between Agenus Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).

AutoNDA by SimpleDocs
Common Stock ($0.01 Par Value)
Underwriting Agreement • January 11th, 2002 • Antigenics Inc /De/ • Biological products, (no disgnostic substances) • New York
Common Stock ($0.01 Par Value)
Underwriting Agreement • January 27th, 2003 • Antigenics Inc /De/ • Biological products, (no disgnostic substances) • New York
Recitals
Lease • May 7th, 2004 • Antigenics Inc /De/ • Biological products, (no disgnostic substances)
AGREEMENT
Employment Agreement • February 26th, 2007 • Antigenics Inc /De/ • Biological products, (no disgnostic substances) • Massachusetts
MiNK Therapeutics, Inc. (a Delaware corporation) 3,333,334 Shares of Common Stock UNDERWRITING AGREEMENT
Underwriting Agreement • October 28th, 2021 • Agenus Inc • Biological products, (no disgnostic substances) • New York
LEASE
Lease Agreement • January 8th, 2003 • Antigenics Inc /De/ • Biological products, (no disgnostic substances)
RECITALS
Sublease Agreement • August 13th, 2002 • Antigenics Inc /De/ • Biological products, (no disgnostic substances) • Massachusetts
AMONG
Merger Agreement • April 24th, 2001 • Antigenics Inc /De/ • Biological products, (no disgnostic substances) • Delaware
WITNESSETH
License Agreement • February 3rd, 2000 • Antigenics Inc /De/ • Biological products, (no disgnostic substances) • Florida
AGENUS INC. Shares of Common Stock (par value $0.01 per share) Controlled Equity OfferingSM Sales Agreement
Sales Agreement • October 18th, 2017 • Agenus Inc • Biological products, (no disgnostic substances) • New York

Agenus Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. (the “Agent”), as follows:

RECITALS
License Agreement • August 27th, 2003 • Antigenics Inc /De/ • Biological products, (no disgnostic substances) • Connecticut
AGREEMENT
Employment Agreement • February 26th, 2007 • Antigenics Inc /De/ • Biological products, (no disgnostic substances) • New York
AGENUS INC. Common Stock (par value $0.01 per share) At Market Issuance Sales Agreement
At Market Issuance Sales Agreement • July 22nd, 2020 • Agenus Inc • Biological products, (no disgnostic substances) • New York
AutoNDA by SimpleDocs
RECITALS:
Patent License Agreement • February 3rd, 2000 • Antigenics Inc /De/ • Biological products, (no disgnostic substances) • New York
INDENTURE
Indenture • November 27th, 2001 • Antigenics Inc /De/ • Biological products, (no disgnostic substances) • Massachusetts
LOAN AND SECURITY AGREEMENT
Loan and Security Agreement • May 10th, 2013 • Agenus Inc • Biological products, (no disgnostic substances) • New York

THIS LOAN AND SECURITY AGREEMENT (this “Agreement”) dated as of April 15, 2013 (the “Effective Date”) among (a) SILICON VALLEY BANK, a California corporation with a loan production office located at 275 Grove Street, Suite 2-200, Newton, Massachusetts 02466 (“Bank”), and (b) AGENUS INC., a Delaware corporation (“Agenus”) and ANTIGENICS INC., a Massachusetts corporation (“Antigenics”) (Agenus and Antigenics are individually and collectively, jointly and severally, “Borrower”), provides the terms on which Bank shall lend to Borrower and Borrower shall repay Bank. The parties agree as follows:

SUBSCRIPTION AGREEMENT FOR LIMITED PARTNERSHIP INTEREST IN APPLIED GENOMIC TECHNOLOGY CAPITAL FUND, L.P.
Subscription Agreement • August 14th, 2000 • Antigenics Inc /De/ • Biological products, (no disgnostic substances) • Delaware
IT IS AGREED:
Research Agreement • March 31st, 2005 • Antigenics Inc /De/ • Biological products, (no disgnostic substances) • Connecticut
RECITALS
Stockholder Voting Agreement • April 24th, 2001 • Antigenics Inc /De/ • Biological products, (no disgnostic substances) • Delaware
AND
Asset Purchase Agreement • April 1st, 2004 • Antigenics Inc /De/ • Biological products, (no disgnostic substances) • Massachusetts
RECITALS
Right of First Refusal Agreement • May 27th, 2004 • Antigenics Inc /De/ • Biological products, (no disgnostic substances) • Delaware
RECITALS
License Agreement • May 15th, 2003 • Antigenics Inc /De/ • Biological products, (no disgnostic substances) • Connecticut
WITNESSETH:
Employment Agreement • November 30th, 1999 • Antigenics Inc /De/ • New York
AGENUS INC. 19,335,653 Shares of Common Stock1 UNDERWRITING AGREEMENT
Underwriting Agreement • February 6th, 2014 • Agenus Inc • Biological products, (no disgnostic substances) • Illinois
Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!